An Emmy Award winner, Jerry Penacoli has covered many of Extra’s high-profile and exclusive interviews, such as Angelina Jolie, Brad Pitt, George Clooney and President Obama. Through all the glitz and glam of the entertainment world, Jerry’s melanoma diagnosis was a shocking reality check.
Early detection of skin cancer can save your skin and, in some cases, even your life. Watch for these clues, and if something doesn’t heal, is growing or just doesn’t seem right, see a dermatologist right away.
Firefighters risk their lives running into burning buildings, but the menace doesn’t come just from the fire. They may face an increased risk for developing melanoma, the most dangerous of the three most common types of skin cancer.
Growing up in Philadelphia and Queens, New York, I wasn’t really an outdoorsy type of child. I spent a lot of time in the dance studio doing ballet, tap and jazz. I did go to Greece every summer, which is where my family is originally from, and I spent a lot of time in the sun on the beaches there. I have that Mediterranean olive skin, and I tanned well.
A recent encounter during a free screening on our Destination: Healthy Skin RV showed, once again, how imperative it is to check in with your skin regularly. It could very well save you time and money in the future, and may even save your life.
Growing up in the 1960s and 1970s, we had a different relationship with the sun. We didn’t think we looked good or “healthy” unless we had a tan. Ironic, isn’t it? I spent many hours in my teens and 20s laying out in the sun – burn, peel, repeat…until the tan took hold.
I recently had a skin cancer removed, and I’m worried about recurrence. I know I’m now at higher risk for more skin cancers, but can that same cancer come back even after it’s been treated?
Each year, we award several grants to dermatology residents, fellows and young faculty to fund research and clinical studies related to skin cancer. This year, the Todd Nagel Memorial Award was given to Dr. William Damsky, researcher at Yale University, for his study “Elucidating and Overcoming Mechanisms of Immunotherapy Resistance in Melanoma.”
With the recent FDA approval of the drug nivolumab (Opdivo®, previously approved for stage IV melanoma) as a treatment for stage III melanoma, we have reached the next important phase in the immunotherapy revolution. It is a revolution that most of the world’s top experts believe will one day, very possibly within a decade, turn advanced (stages III and IV) melanoma into a chronic, or even curable, disease rather than a deadly one.
In the summer of 2006, Kevin noticed a mole on his shoulder that seemed to have changed colors, so he went to see a dermatologist. A biopsy determined that the mole was a malignant melanoma.